{"originalText": "，患者6个月前（2014-5）无明显诱因出现排便习惯改变，大便2-4次/日，呈稀糊状，伴里急后重感，无脓血，无腹痛腹胀，无恶心呕吐，无发热，自诉口服中药（具体不详）效果不明显。遂就诊于我院消化内科，2014年7月9日，行肠镜检查示：，直肠：肛缘至距肛缘约7CM见约环2/3管腔不规则隆起病变，表面糜烂结节状。，诊断意见：直肠CARCINOMA。2014年7月16日于我院胃肠外科在全麻上行腹会阴直肠癌根治术（MILES手术），术中见肿瘤位于腹膜返折上方，巨大充满小骨盆腔，，术后病理示：距肛门侧切缘4CM处，肠粘膜面见8*7*2.5CM灰白溃疡型肿物，，诊断意见：A(直肠肿瘤)，:黏液腺癌(中低分化)，侵及外膜；L251(14/14)、L252(3/8)，：淋巴结转移癌；L253(0/1)，：淋巴结淋巴组织增生（，病理号：Z0480550）。，免疫组化：，A2：C-ERBB-2(1+) D2-40(-) CEA(+) CK20(+) CK7(-) KI-67(约50%+) CD34(-)。术后恢复可，于我科行XELOX方案化疗3周期，，具体用药：艾恒 200MG D1 静点，希罗达 1500MG 日二次口服。末次化疗后出现I°粒细胞上降，未治疗。现为行进一步治疗收入我科。患者目前一般状况可，无发热，无腹痛、腹泻及便血，饮食睡眠可，二便正常，周身无疼痛，病来体重无明显减轻，ECOG评分1分。", "entities": [{"end_pos": 56, "label_type": "解剖部位", "overlap": 0, "start_pos": 55}, {"end_pos": 58, "label_type": "解剖部位", "overlap": 0, "start_pos": 57}, {"end_pos": 119, "label_type": "解剖部位", "overlap": 0, "start_pos": 117}, {"end_pos": 122, "label_type": "解剖部位", "overlap": 0, "start_pos": 120}, {"end_pos": 126, "label_type": "解剖部位", "overlap": 0, "start_pos": 124}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 160, "end_pos": 171}, {"label_type": "手术", "overlap": 0, "start_pos": 194, "end_pos": 212}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 220, "end_pos": 221}, {"end_pos": 235, "label_type": "解剖部位", "overlap": 0, "start_pos": 231}, {"end_pos": 246, "label_type": "解剖部位", "overlap": 0, "start_pos": 244}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 254, "end_pos": 255}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 284, "end_pos": 288}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 291, "end_pos": 295}, {"end_pos": 479, "label_type": "药物", "overlap": 0, "start_pos": 477}, {"end_pos": 496, "label_type": "药物", "overlap": 0, "start_pos": 492}, {"end_pos": 557, "label_type": "解剖部位", "overlap": 0, "start_pos": 556}, {"end_pos": 560, "label_type": "解剖部位", "overlap": 0, "start_pos": 559}]}
